← All stocks

Oruka Therapeutics, Inc.

ORKA Mostly scheduled
CIK 0000907654 #1126 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$10.21M
$53.60K on a plan · $9.74M straight out of an exercise
Sold at will
$420.84K
3 of 22 sales
Net
−$10.21M
−$420.84K against sales at will

By person

9 insiders · 22 transactions
141×

Lawrence Klein holds 141 times base salary in stock. $88.35M of shares against $624.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Lawrence Klein last reported holding, valued at $95.71, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Klein Lawrence Otto
Chief Executive Officer
$7.12M (4) scheduled
−$7.12M
923,128
1.39%
$88.35M
+8.3%
Goncalves Joana
Chief Medical Officer
$1.52M (9) scheduled
−$1.52M
31,771
0.0480%
$3.04M
+1,659%
Agarwal Arjun
Senior Vice President, Finance
$926.01K (5) scheduled
−$926.01K
14,752
0.0223%
$1.41M
+457.5%
Sandler Laura Lee
Chief Operating Officer
$545.81K (3) scheduled
−$545.81K
235,478
0.3557%
$22.54M
+10.5%
Quinlan Paul T
General Counsel
$99.44K (1)
−$99.44K
29,995
0.0453%
$2.87M
Venrock Healthcare Capital Partners III, L.P. entity
10% owner
4,148,428
6.27%
$397.05M
+3.1%
Fairmount Funds Management LLC entity
Director
1,131,954
1.71%
$108.34M
+77.3%
Edwards Larry Todd
Chief Commercial Officer
100,000
0.1510%
$9.57M
Dambkowski Carl
Director
38,743
0.0585%
$3.71M
Insider
Date
Role
Action
Shares
Price
Amount
Sandler Laura Lee
15 Sep 2026
Chief Operating Officer
Sell
906
$95.71
$86.71K
Quinlan Paul T
15 Sep 2026
General Counsel
Sell
1,039
$95.71
$99.44K
Klein Lawrence Otto
15 Sep 2026
Chief Executive Officer
Sell
2,452
$95.71
$234.68K
Agarwal Arjun
15 Sep 2026
Senior Vice President, Finance
Sold on a plan
560
$95.71
$53.60K
Goncalves Joana
15 Sep 2026
Chief Medical Officer
Sold after exercise
947
$95.71
$90.64K
Goncalves Joana
15 Sep 2026
Chief Medical Officer
Sold after exercise
100
$94.22
$9.42K
Goncalves Joana
15 Sep 2026
Chief Medical Officer
Sold after exercise
1,366
$92.99
$127.02K
Goncalves Joana
15 Sep 2026
Chief Medical Officer
Sold after exercise
3,150
$92.03
$289.89K
Goncalves Joana
15 Sep 2026
Chief Medical Officer
Sold after exercise
2,384
$91.10
$217.17K
Agarwal Arjun
11 Sep 2026
Senior Vice President, Finance
Sold after exercise
200
$94.02
$18.80K
Agarwal Arjun
11 Sep 2026
Senior Vice President, Finance
Sold after exercise
2,208
$93.26
$205.92K
Agarwal Arjun
11 Sep 2026
Senior Vice President, Finance
Sold after exercise
4,051
$92.41
$374.37K
Agarwal Arjun
11 Sep 2026
Senior Vice President, Finance
Sold after exercise
3,000
$91.11
$273.32K
Klein Lawrence Otto
1 Sep 2026
Chief Executive Officer
Sold after exercise
4,800
$92.44
$443.69K
Klein Lawrence Otto
1 Sep 2026
Chief Executive Officer
Sold after exercise
63,596
$91.90
$5.84M
Klein Lawrence Otto
1 Sep 2026
Chief Executive Officer
Sold after exercise
6,604
$90.79
$599.56K
Sandler Laura Lee
1 Sep 2026
Chief Operating Officer
Sold after exercise
4,000
$92.01
$368.05K
Sandler Laura Lee
1 Sep 2026
Chief Operating Officer
Sold after exercise
1,000
$91.05
$91.05K
Goncalves Joana
17 Aug 2026
Chief Medical Officer
Sold after exercise
2,480
$112.56
$279.15K
Goncalves Joana
17 Aug 2026
Chief Medical Officer
Sold after exercise
3,320
$112.01
$371.89K
Goncalves Joana
17 Aug 2026
Chief Medical Officer
Sold after exercise
300
$110.52
$33.16K
Goncalves Joana
17 Aug 2026
Chief Medical Officer
Sold after exercise
900
$109.65
$98.69K

What was left out

Form 4 filings counted 9
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 18
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 203,459
History held since 21 Sep 2016